These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 17054861

  • 1. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ, Gu LJ, Song DL, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Chen J, Wang YP, Zou JY.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1837-40. PubMed ID: 17054861
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of prognostic variables in childhood acute myeloid leukemia].
    Gu LJ, Tie LJ, Xue HL, Tang JY, Chen J, Pan C, Chen J, Ye H, Wang YP, Dong L.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan 11; 27(1):10-3. PubMed ID: 16732931
    [Abstract] [Full Text] [Related]

  • 3. [Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].
    Zou Y, Wang H, Chen XJ, Wang SC, Zhang L, Chen YM, Zhu XF.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep 11; 27(9):621-5. PubMed ID: 17278430
    [Abstract] [Full Text] [Related]

  • 4. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
    Gu LJ, Tie LJ, Jiang LM, Chen J, Pan C, Dong L, Chen J, Xue HL, Tang JY, Wang YP, Ye H.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr 11; 11(4):241-5. PubMed ID: 19374802
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis].
    Creutzig U, Bender-Götze C, Klingebiel T, Ebell W, Friedrich W, Stollmann-Gibbels B, Schmidt H, Suttorp M, Gratwohl A, Heyen P.
    Klin Padiatr; 1992 Apr 11; 204(4):246-52. PubMed ID: 1518260
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China.
    Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Chen J.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan 11; 11(1):5-9. PubMed ID: 19149913
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2002 Feb 11; 87(2):154-66. PubMed ID: 11836166
    [Abstract] [Full Text] [Related]

  • 8. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2008 Jun 11; 93(6):834-41. PubMed ID: 18469352
    [Abstract] [Full Text] [Related]

  • 9. [Prognosis of children with acute myelocytic leukemia after first relapse].
    Creutzig U, Ritter J, Boos J, Zimmermann M, Bender-Götze C, Stahnke K.
    Klin Padiatr; 1998 Jun 11; 210(4):207-11. PubMed ID: 9743954
    [Abstract] [Full Text] [Related]

  • 10. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U.
    Klin Padiatr; 2002 Jun 11; 214(4):188-94. PubMed ID: 12165900
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Wang YP, Chen J.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 11; 26(1):6-9. PubMed ID: 15946500
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR, Zemanova Z, Stary J, Bourquin JP, Haas OA, Dworzak MN, Creutzig U.
    J Clin Oncol; 2010 Jun 01; 28(16):2682-9. PubMed ID: 20439630
    [Abstract] [Full Text] [Related]

  • 13. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
    Tomás JF, Gómez-García de Soria V, Pinilla I, Lamana M, Figuera A, Arranz R, Cámara R, Fernández-Villalta MJ, Alegre A, Fernández-Rañada JM.
    Med Clin (Barc); 1997 Feb 15; 108(6):201-6. PubMed ID: 9102484
    [Abstract] [Full Text] [Related]

  • 14. Maintenance therapy in childhood acute myeloid leukemia.
    Perel Y, Auvrignon A, Leblanc T, Michel G, Vannier JP, Dalle JH, Gandemer V, Schmitt C, Mèchinaud F, Lamagnere JP, Piguet Ch, Couillaud G, Pautard B, Baruchel A, Leverger G, Group LAME, French Society of Pediatric Hematology and Immunology.
    Ann Hematol; 2004 Feb 15; 83 Suppl 1():S116-9. PubMed ID: 15124700
    [Abstract] [Full Text] [Related]

  • 15. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
    Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Bénard A, Bordigoni P, Gandemer V, Thuret I, Dalle JH, Piguet C, Pautard B, Baruchel A, Leverger G, French Society of Pediatric Hematology and Immunology.
    J Clin Oncol; 2003 Dec 01; 21(23):4377-85. PubMed ID: 14645428
    [Abstract] [Full Text] [Related]

  • 16. [Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia].
    Li J, Gu LJ, Xue HL, Tang JY, Chen J, Zhao HJ, Chen J, Pan C, Wang YP, Ye H.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jun 01; 25(6):351-4. PubMed ID: 15308014
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A, Nagatoshi Y, Inada H, Nakayama H, Yanai F, Ayukawa H, Kawakami K, Moritake H, Suminoe A, Okamura J.
    Pediatr Blood Cancer; 2005 Aug 01; 45(2):111-20. PubMed ID: 15782402
    [Abstract] [Full Text] [Related]

  • 18. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.
    Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH, Sandler ES, Yeager AM, Edwards JR, Horowitz MM.
    J Clin Oncol; 2004 Sep 15; 22(18):3798-804. PubMed ID: 15365077
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.
    Cancer; 2005 Jan 15; 103(2):368-76. PubMed ID: 15599932
    [Abstract] [Full Text] [Related]

  • 20. Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report.
    Berger M, Ferrero I, Vassallo E, Gastaldo L, Carraro F, Biasin E, Madon E, Fagioli F.
    Pediatr Hematol Oncol; 2005 Jan 15; 22(7):597-608. PubMed ID: 16166053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.